Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.

Register for Details

For more details on financing and valuation for Nurx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Nurx Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/11/2020 Series C-1 $317.71MM $XXX.XX $XXX.XX
8/15/2019 Series C $291.17MM $XXX.XX $XXX.XX
7/11/2018 Series B-1 and B-2 $113.57MM $XXX.XX $XXX.XX
11/3/2016 Series A-1, A-2, A-3, and A-4 $20.77MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Nurx

Forge green plus iconForge green minus icon

What is Nurx funding to date?

Nurx has raised $90.87MM with the following series:
$20.77MM for Series A-1, A-2, A-3, and A-4, $113.57MM for Series B-1 and B-2, $291.17MM for Series C, $317.71MM for Series C-1, $20.77MM for Series A-1, A-2, A-3, and A-4, $113.57MM for Series B-1 and B-2, $291.17MM for Series C, $317.71MM for Series C-1.
Forge green plus iconForge green minus icon

When was Nurx founded?

Nurx was founded in 2015.